¥25.63 ($3.82)

+0.76 (+3.06%)

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 44 · ¥23.6B mcap · 340M float · 1.91% daily turnover

Revenue

$8.0B -17.0% ▼

5Y CAGR: +2.9%

Gross Profit

$6.4B -19.3% ▼

5Y CAGR: +1.7%

Operating Income

$2.9B -12.1% ▼

5Y CAGR: +9.0%

Net Income

$2.5B -10.3% ▼

5Y CAGR: +9.3%

EPS (Diluted)

$2.76 -10.4% ▼

5Y CAGR: +6.8%

EBITDA

$2.7B -14.4% ▼

5Y CAGR: +6.0%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$6.2B	$7.6B	$9.0B	$9.7B	$8.0B
YoY Growth	-11.2%	+23.8%	+17.9%	+7.3%	-17.0%
Cost of Revenue	$1.1B	$1.3B	$1.5B	$1.8B	$1.7B
Gross Profit	$5.0B	$6.4B	$7.5B	$7.9B	$6.4B
Gross Margin	81.7%	83.3%	82.9%	81.5%	79.2%
R&D Expenses	$244M	$523M	$553M	$464M	$462M
SG&A Expenses	$3.3B	$4.0B	$4.5B	$4.4B	$3.4B
Operating Expenses	$3.6B	$4.4B	$5.0B	$4.6B	$3.5B
Operating Income	$1.5B	$1.9B	$2.4B	$3.3B	$2.9B
Operating Margin	23.8%	25.3%	26.9%	33.7%	35.7%
Interest Expense	$34M	$35M	$31M	$18M	$27M
Income Before Tax	$1.5B	$2.0B	$2.5B	$3.3B	$3.0B
Tax Expense	$206M	$233M	$336M	$470M	$442M
Net Income	$1.3B	$1.7B	$2.2B	$2.8B	$2.5B
Net Margin	20.7%	22.5%	24.1%	29.2%	31.6%
EPS (Diluted)	$1.53	$1.91	$2.39	$3.08	$2.76
EBITDA	$1.7B	$2.0B	$2.6B	$3.2B	$2.7B
Shares Outstanding	835M	899M	908M	916M	917M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.8B	$2.2B	$1.5B	$1.2B	$1.2B	$2.3B	$1.2B	$1.1B
Cost of Revenue	$380M	$462M	$347M	$323M	$264M	$376M	$216M	$292M
Gross Profit	$1.4B	$1.7B	$1.2B	$901M	$919M	$1.9B	$992M	$829M
Gross Margin	78.5%	79.1%	77.3%	73.6%	77.7%	83.6%	82.1%	74.0%
R&D Expenses	$89M	$165M	$101M	$89M	$82M	$113M	$107M	$0
SG&A Expenses	$692M	$895M	$660M	$527M	$474M	$426M	$531M	$0
Operating Expenses	$729M	$1.0B	$676M	$570M	$578M	$1.0B	$519M	$542M
Operating Income	$662M	$743M	$502M	$331M	$341M	$872M	$473M	$287M
Operating Margin	37.4%	33.6%	32.9%	27.1%	28.9%	38.2%	39.2%	25.6%
Interest Expense	$7M	$5M	$4M	$4M	$2M	$2M	$6M	$7M
Income Before Tax	$666M	$745M	$515M	$334M	$411M	$902M	$474M	$458M
Tax Expense	$100M	$115M	$73M	$50M	$113M	$148M	$75M	$75M
Net Income	$565M	$629M	$440M	$284M	$298M	$755M	$400M	$385M
Net Margin	31.9%	28.4%	28.9%	23.2%	25.2%	33.0%	33.1%	34.4%
EPS (Diluted)	$0.62	$0.69	$0.48	$0.31	$0.33	$0.82	$0.44	$0.41
EBITDA	$667M	$704M	$507M	$317M	$414M	$981M	$480M	$369M
Shares Outstanding	916M	917M	917M	916M	915M	917M	918M	928M

600566.SS SHH